Research in Social & Administrative Pharmacy最新文献

{"title":"Identifying clinician-reported medication \"Failure modes\" in the nursing home setting that are amenable to active monitoring.","authors":"Chenyu Li, Olga Kravchenko, Eric Chou, Steven M Handler, Nicole E Hume, Katrina Romagnoli, Jordan F Karp, Douglas P Landsittel, Sandra L Kane-Gill, Matthew P Gray, Steven Albert, Nicholas G Castle, Charles F Reynolds, Richard D Boyce","doi":"10.1016/j.sapharm.2026.04.008","DOIUrl":"https://doi.org/10.1016/j.sapharm.2026.04.008","url":null,"abstract":"<p><strong>Objectives: </strong>Nursing home residents are at high-risk for preventable harm and medication errors. This study aimed to identify clinician-reported medication safety failure modes in U.S. nursing homes and prioritize those most suitable for informatics-enabled active monitoring interventions.</p><p><strong>Methods: </strong>We conducted a mixed-methods failure mode and effects analysis. Semi-structured interviews and field observations were conducted with 23 nursing home clinicians (duration 60-90 min). Interview anecdotes were translated into stepwise failure modes and represented as Unified Modeling Language (UML) workflow diagrams. Respondents rated each scenario's perceived seriousness, detectability, and frequency of routine monitoring; these ratings were combined to identify high-priority targets for intervention.</p><p><strong>Results: </strong>Fourteen failure modes were refined into 10 generalizable clinical scenarios and evaluated via a survey of 61 nursing home healthcare providers from a wide range of sites and roles. Across clinical roles, survey respondents consistently prioritized meclizine/psychotropic co-exposure and diuretic/mobility impairment co-exposure as high-priority scenarios for active monitoring. Scenarios involving psychotropic/CNS-active medications and potential drug-drug interactions were also frequently rated as important and not routinely monitored.</p><p><strong>Conclusions: </strong>Clinician-derived medication nursing home safety failure modes have been prioritized using multi-stakeholder survey input, yielding a focused set of targets for medication-safety monitoring in nursing homes.</p><p><strong>Implications: </strong>The identified high-priority scenarios can inform the design of automated monitoring tools and pharmacist/nursing workflows. Future work should validate these targets against resident outcomes and evaluate the effectiveness of monitoring interventions.</p>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2026-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147785842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"An equation-based conceptual framework of personal and professional development in pharmacy practice.","authors":"Mohanad Odeh, Logan T Murry, Shane Desselle","doi":"10.1016/j.sapharm.2026.04.007","DOIUrl":"https://doi.org/10.1016/j.sapharm.2026.04.007","url":null,"abstract":"<p><p>Pharmacy practice continues to expand in scope, complexity, and accountability, increasing the need for continuing pharmacy education (CPE) and continuing professional development (CPD) approaches that translate learning into sustained practice improvement while integrating personal and professional growth. Despite widespread adoption of CPD frameworks, evidence across settings indicates variable uptake and inconsistent impact, reflecting a persistent implementation gap between participation and durable practice change. To inform framework development, we conducted a narrative review of CPE/CPD frameworks in pharmacy, with attention to intended outcomes, factors shaping uptake and impact. This synthesis inspired an examination into current gaps in consistent CPE/CPD implementation and thusly a proposal of an equation-based conceptual framework: Personal and Professional Development = (Competence × Commitment) ^{(Behaviour+Attitude)}. In the framework, competence (knowledge + skills) and commitment (motivation + confidence) form the baseline term; multiplication reflects interdependence such that when either component approaches zero, development correspondingly collapses; addition reflects compensatory strengths within each term; and exponentiation positions behaviour and attitude as scaling forces that can suppress, neutralise, or amplify development. The framework provides a parsimonious diagnostic lens for identifying the dominant constraint (baseline versus scaling term) and prioritising intervention targets across diverse learner profiles. It is advanced as a practical heuristic to structure reflective CPE/CPD and personal development planning, support mentorship and performance-development conversations, and guide prioritisation of development efforts at individual and team levels. The framework focuses on intra-individual determinants offering a clear platform for future context-specific operationalization. By translating common development challenges into an accessible diagnostic structure, the framework provides a shared language for converting reflection into targeted action and sustained practice improvement.</p>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2026-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147822225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effect of different frequencies of intermittently scanned continuous glucose monitoring on glycemic control in adults with type 2 diabetes not using insulin: The COMPASS-libre randomized controlled trial.","authors":"Hiroshi Okada, Shota Suzuki, Masayuki Domichi, Naoki Sakane","doi":"10.1016/j.sapharm.2026.04.005","DOIUrl":"https://doi.org/10.1016/j.sapharm.2026.04.005","url":null,"abstract":"<p><strong>Background and objective: </strong>Intermittently scanned continuous glucose monitoring (isCGM) has been shown to improve glycemic control in individuals with type 2 diabetes mellitus (T2DM), yet the optimal frequency of CGM use remains unclear, particularly in community pharmacy settings. This study evaluated the effects of different frequencies of isCGM use within a brief pharmacist-led educational program for adults with T2DM treated without insulin.</p><p><strong>Methods: </strong>The COMPASS-Libre study was a multicenter, open-label randomized controlled trial conducted in community pharmacies in Japan. Adults with T2DM and glycated hemoglobin (HbA1c) ≥7% were randomized (1:1) to either a single-CGM group (one sensor) or a multiple-CGM group (four sensors) over 12 weeks. The primary outcome was change in time in range (TIR; glucose 70-180 mg/dL). Secondary outcomes included time above range (TAR), time below range (TBR), glucose management indicator (GMI), and coefficient of variation (%CV), along with behavioral and patient-reported outcomes.</p><p><strong>Results: </strong>Seventy-seven participants were randomized (mean age 60.9 ± 10.4 years; mean HbA1c 7.4 ± 0.8%), with a dropout rate of 16.8%. TIR significantly improved in both the single-CGM group (64.6 ± 23.0% to 71.1 ± 17.9%, P = 0.0496) and the multiple-CGM group (62.5 ± 20.8% to 69.6 ± 21.7%, P = 0.002), with no significant between-group difference in change (6.4 ± 17.1% vs 7.3 ± 12.0%, P = 0.808). TAR decreased significantly in both groups, while TBR remained low and unchanged. GMI also improved in both groups, with no significant between-group differences. Improvements in dietary behavior were observed only in the multiple-CGM group (P = 0.032).</p><p><strong>Conclusions: </strong>A brief pharmacist-led educational program using intermittently scanned CGM improved glycemic metrics in adults with non-insulin-treated T2DM. However, increasing the frequency of CGM use did not provide additional glycemic benefit compared with a single CGM exposure. These findings suggest that even limited CGM use may support behavioral change and glycemic improvement in community pharmacy settings.</p><p><strong>Trial registration: </strong>UMIN000048893.</p>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2026-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147724501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"An international scoping review of opioid-related stigma interventions within the pharmacy profession.","authors":"Darcy Gibson, Ian Towle, Derna Campbell, Emma Dunlop, Adrian MacKenzie, Andrew Radley, Natalie Weir","doi":"10.1016/j.sapharm.2026.04.002","DOIUrl":"https://doi.org/10.1016/j.sapharm.2026.04.002","url":null,"abstract":"<p><p>Opioid-related stigma within the pharmacy profession can prevent people with substance use disorders receiving necessary care. Stigmatisation can negatively impact individuals' interactions with healthcare professionals, reduce engagement with harm reduction services, and deter individuals from seeking treatment. The aim of this study is to identify the educational interventions aimed at addressing opioid-related stigma within pharmacy teams. A scoping review was conducted following the Arksey and O'Malley framework. The search was conducted in October 2024 using MEDLINE, EMBASE, and PSYCINFO. Data from included studies were extracted and categorised into tables for comparison, according to their intervention focus following an analysis of the intervention details. A narrative summary of the included studies, their main characteristics, findings, and reported barriers was conducted. Eleven studies were included, mostly from the USA, encompassing four main intervention types: educational training programmes; toolkit-based interventions; harm reduction training and screening; and brief intervention implementation. Most interventions demonstrated stigma reduction, particularly those incorporating direct patient interactions, stigma-free language training and harm reduction awareness. Barriers to implementation include time constraints, lack of resources and staff hesitancy. Interventions targeting opioid-related stigma show promising results in improving attitudes and reducing discriminatory behaviours in a pharmacy setting. Pharmacists, as accessible healthcare providers, are well-positioned to support harm reduction efforts and foster stigma-free environments. Future research should focus on standardised evaluation methods, research outside of the USA, and long-term stigma reduction strategies.</p>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2026-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147785760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Integrating key interest-holder perspectives on the use of patient-reported experience measures for medications: a mixed methods study.","authors":"Jacob Crawshaw, Rasha El-Kotob, Lauren Cadel, Lisa M McCarthy, Lisa Dolovich, Sander L Hitzig, Diana Zidarov, Crystal MacKay, Stephanie R Cimino, James Milligan, Aisha Lofters, Sara J T Guilcher","doi":"10.1016/j.sapharm.2026.04.004","DOIUrl":"https://doi.org/10.1016/j.sapharm.2026.04.004","url":null,"abstract":"<p><strong>Background: </strong>Integrating patient-reported experience measures (PREMs) into medication management could strengthen patient-centred care. However, few tools capture patients' experiences with medications (PREM-Rx) in primary care, including community pharmacy. This study examined factors impacting the implementation of PREM-Rx from key interest-holders' perspectives.</p><p><strong>Methods: </strong>We conducted a three-phase sequential mixed methods study in Ontario, Canada. Phase 1 involved semi-structured interviews with key interest-holders, including persons with lived experience (PWLE) of medication use (n = 21), medication prescribers (n = 20), and health system decision-makers (n = 9). Phase 2 comprised a cross-sectional survey of PWLE (n = 197) and prescribers/decision-makers (n = 200). In Phase 3, we used a triangulation protocol to integrate qualitative and quantitative findings using the Theoretical Domains Framework (TDF).</p><p><strong>Results: </strong>Integration identified convergence across seven TDF domains: Knowledge, Skills, Beliefs about capabilities, Beliefs about consequences, Behavioural regulation, Goals, and Environmental context and resources, with additional alignment in PREM-Rx delivery preferences. Key interest-holders agreed that PREM-Rx could promote safer medication use, but identified gaps in awareness, confidence, and system-level supports. PWLE prioritized shared decision-making and medication safety during conversations about medications, while prescribers emphasized potential workflow and resource constraints of implementing PREM-Rx without additional supports alongside. Delivery preferences of PREM-Rx included short completion time, accessible formats, and flexible delivery, with most PWLE preferring primary care and most prescribers favoring community pharmacy.</p><p><strong>Conclusions: </strong>PREM-Rx are promising tools for eliciting medication-related experiences in routine care. Implementation efforts should focus on building user confidence, integrating PREM-Rx into existing workflows, and tailoring delivery to patient and prescribers needs to inform targeted implementation strategies.</p>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2026-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147785772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Improving medication safety through behavioral nudges: An evaluation of unit sales trends following a pharmacy-based intervention.","authors":"Shiying Mai, Aaron M Gilson, Ronald E Gangnon, Jamie A Stone, Kenneth D Walker, Joel D Gollhardt, Michelle A Chui","doi":"10.1016/j.sapharm.2026.04.003","DOIUrl":"https://doi.org/10.1016/j.sapharm.2026.04.003","url":null,"abstract":"<p><strong>Background: </strong>Over-the-counter (OTC) medication misuse among older adults is a patient safety concern, exacerbated by limited patient engagement about potential risks. Senior Safe™, a pharmacy-based intervention using human-factors engineering and participatory design,specifically, shelf signage, product repositioning, and patient engagement to nudge safer choices. Despite its safety intent, and demonstrated effectiveness, it was important to determine the intervention's impact on its financial sustainability.</p><p><strong>Methods: </strong>This study evaluated Senior Safe's effect on daily unit sales of OTC analgesic, sleep, and cough/cold/allergy products across 65 community pharmacies in a Midwestern health system. Using Generalized Linear Mixed Model regressions with Poisson distribution, the analyses compared daily unit sales pre- and post-intervention trends for products marked with Green Banners (safer), Red Stop Signs (high-risk), or Behind-the-Counter (BTC) signage (very high-risk), controlling for pharmacy type, size, location, open hours, and staff hours.</p><p><strong>Results: </strong>Senior Safe was associated with increased sales of safer analgesics and cough/cold/allergy medications (IRR = 1.064 and 1.106), along with significant decreases in unit sales of BTC and Red Stop Sign products (IRR = 0.424-0.869). These findings suggest a substitution effect, where patients chose safer alternatives rather than forgoing OTC purchases. Operational factors, such as longer open hours and higher staffing levels, were positively associated with safer product unit sales.</p><p><strong>Conclusions: </strong>Senior Safe successfully shifted consumer behavior toward safer OTC medication use without reducing overall sales volume, suggesting patient safety interventions can be financially sustainable in retail pharmacy settings. These results support broader implementation of low-cost, system-level interventions that align safety with business operations.</p>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2026-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147655184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Doing things differently: Integrating evidence-based marketing frameworks into pharmacy practice to promote respiratory health services","authors":"Simone Tan ,&nbsp;Lynne Emmerton ,&nbsp;Billy Sung ,&nbsp;Bandana Saini ,&nbsp;Tin Fei Sim","doi":"10.1016/j.sapharm.2025.12.003","DOIUrl":"10.1016/j.sapharm.2025.12.003","url":null,"abstract":"<div><div>Accessible health services play a crucial role in the management of chronic conditions such as asthma and chronic obstructive pulmonary disease, and the associated reduction in their corresponding morbidity and mortality rates. The evolution of the community pharmacist's role, combined with the highly accessible community pharmacy setting, positions pharmacists as key providers of timely, preventive, and supportive interventions for respiratory health.</div><div>Despite the use of theories such as the Capability, Opportunity, Motivation, and Behavior (COM-B) model or Theoretical Domains Framework to guide the implementation of professional services, the uptake of respiratory health services in community pharmacies remains inconsistent across pharmacies and service types, presenting a lost opportunity to improve outcomes for people living with chronic respiratory conditions. Whilst these frameworks recognize communication and marketing as key factors influencing successful service implementation, they were not developed to guide the systematic marketing, communication, or promotion of these services to patients and the wider community.</div><div>The commercial sector has long leveraged evidence-based marketing frameworks, segmentation and targeting approaches, and promotional strategies to systematically guide the planning, execution, and evaluation of its marketing activities. These frameworks or models are designed to provide clarity and consistency, ensuring that marketing decisions are not <em>ad hoc</em> or reactive, but are instead aligned with the broader goals of the organizations involved. Given the success of these approaches, we assert that adapting such frameworks within pharmacy health services can enhance understanding of consumer psychology and, in turn, enable us to market these services more effectively.</div><div>This commentary advocates the need for exploring how pharmacy services can be better communicated and marketed to potential health consumers, using respiratory health services as an example.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 3","pages":"Pages 501-503"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145709928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Outcomes of pharmacist interventions as part of EAHOP – Enhancing allied health for older people in residential care","authors":"Rachel L. Hill ,&nbsp;Nathan M. D'Cunha ,&nbsp;Sam Kosari ,&nbsp;Claire Pearce ,&nbsp;Mark Naunton ,&nbsp;Helen Holloway ,&nbsp;Kasia Bail ,&nbsp;Diane Gibson ,&nbsp;Stephen Isbel","doi":"10.1016/j.sapharm.2025.11.008","DOIUrl":"10.1016/j.sapharm.2025.11.008","url":null,"abstract":"<div><div>The EAHOP trial (Enhancing Allied Health for Older People in Residential Care) Outcomes of pharmacist interventions.</div></div><div><h3>Background</h3><div>The pharmacist has a critical role in the multidisciplinary team (MDT) when contributing to the care of older people living in residential aged care. The EAHOP study is a clinical trial that embedded a pharmacist within an MDT in a residential aged care home. This abstract reports on the pharmacy results of the study.</div></div><div><h3>Method</h3><div>This study used a mixed method to describe key pharmacy outcome measures of direct and indirect time per resident, number of recommendations accepted and to describe the thoughts, opinions and experience of key stakeholders.</div></div><div><h3>Results</h3><div>There were 124 recommendations made by the pharmacist for 34 residents, an average of 3.65 per resident, higher than the usual 2.7 recommendations per RMMR. At the GP case conferences 70 % were accepted, 9 % were declined and 21 % were not discussed. An average of 61 min direct time and 246 min of indirect time was spent per resident. Qualitative findings showed the pharmacy role improved care for residents by enhancing communication between health professionals, staff, residents and families.</div></div><div><h3>Conclusion</h3><div>The EAHOP model can supplement existing models of pharmacy intervention in residential care by providing organised multidisciplinary collaboration between the General Practitioner, nursing, pharmacist and allied health disciplines.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 3","pages":"Pages 435-442"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145655631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Exploring the readiness of healthcare providers for scaling up telehealth services beyond the COVID-19 pandemic: A mixed method study","authors":"Sofa D. Alfian ,&nbsp;Qisty A. Khoiry ,&nbsp;Hasna S.M. Isman ,&nbsp;Aulia Iskandarsyah ,&nbsp;Ivan S. Pradipta ,&nbsp;Rizky Abdulah","doi":"10.1016/j.sapharm.2025.12.008","DOIUrl":"10.1016/j.sapharm.2025.12.008","url":null,"abstract":"<div><h3>Background</h3><div>The coronavirus disease 2019 (COVID-19) pandemic accelerated digital health transformation, forcing healthcare providers to immediately implement telehealth services without adequate assessment of their readiness.</div></div><div><h3>Objective</h3><div>This study aims to explore the readiness of healthcare providers to scale up telehealth services in Indonesia.</div></div><div><h3>Methods</h3><div>A sequential mixed method was used with an explanatory study design. A cross-sectional survey using the translated and validated Telehealth Readiness Assessment (TRA) tool was conducted among general practitioners and pharmacists from public clinics in Bandung City, Indonesia. This was followed by a qualitative study using in-depth interviews and focus group discussions (FGDs) to explore the underlying reasons among those who showed low readiness observed from quantitative results. Quantitative and qualitative data analyses were performed for each type of healthcare provider.</div></div><div><h3>Results</h3><div>The results showed that in total, 63 general practitioners and 86 pharmacists, completed the survey, a majority of whom were female including 64 % of general practitioners and 72 % of pharmacists. Most of general practitioners showed moderate readiness, while most of pharmacists demonstrated high readiness to implement telehealth services. There were no significant correlations between readiness to implement telehealth services with age, sex, education level, and duration of experience (p &gt; 0.05). A total of six females aged between 26 and 50 years participated in the in-depth interviews and FGDs. Among those who showed low readiness, organizational leadership, financial considerations, operational difficulties, staff engagement, and patient participation were mentioned as the main reasons. Differences in these underlying reasons were observed between general practitioners and pharmacists.</div></div><div><h3>Conclusion</h3><div>Differences are observed in the levels at which general practitioners and pharmacists are ready to scale up telehealth services. The underlying reasons for the low readiness are specific to the type of healthcare providers and affected by organizational, operational, and technological factors, but independent of sociodemographic factors.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 3","pages":"Pages 482-490"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145865991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Ensuring the quality use of medicines in clinical trials: A review and perspective on optimising the role of pharmacists","authors":"Beata Bajorek","doi":"10.1016/j.sapharm.2025.11.004","DOIUrl":"10.1016/j.sapharm.2025.11.004","url":null,"abstract":"<div><h3>Objectives</h3><div>Given that a most clinical trials investigate potential or established medicines, it should be obvious that pharmacists, as ‘<em>medicines experts</em>’, would play a key role in such. The aim of this article was to narrate a perspective on the role of the pharmacist in clinical trials, drawing out the way that pharmacists are currently represented within clinical trials guidance documents.</div></div><div><h3>Methods</h3><div>This narrated review and perspective explored relevant international literature relating to clinical trial governance, particularly from the Australian setting where such documents have been recently developed and/or revised, providing a contemporary representation.</div></div><div><h3>Results</h3><div>Clinical trial guidance documents describing the role of pharmacists show that quality use of medicines principles are not well applied to the trial context. As such, pharmacists are underutilised in their role as medicines experts and as clinicians supporting optimal medicines use along the medication management pathway. Presently, guidance documents portray pharmacists as having largely administrative roles, focused on compliance with trial protocols, policies and legislation. Any clinical role appears relatively limited to drug handling. There is a need for capacity building in clinical trial to better recognise and utilise pharmacists’ expertise, including them in the design, conduct, and leadership of clinical trials.</div></div><div><h3>Conclusions</h3><div>There is both scope and need to more directly include pharmacists in clinical trials. Wherever medicines are used, a pharmacist should be present and/or substantively involved in assuring the quality use of medicines, including within the full range of clinical trials. To support pharmacists, part of the global investment into clinical research should include an investment into clinical pharmacy services to ensure the quality use of medicines throughout the trial process alongside effective translation into clinical practice.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 3","pages":"Pages 363-369"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145641296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}